Gray-Level Co-occurrence Matrix Analysis of Nuclear Textural Patterns in Laryngeal Squamous Cell Carcinoma: Focus on Artificial Intelligence Methods.

Journal: Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada
PMID:

Abstract

Gray-level co-occurrence matrix (GLCM) and discrete wavelet transform (DWT) analyses are two contemporary computational methods that can identify discrete changes in cell and tissue textural features. Previous research has indicated that these methods may be applicable in the pathology for identification and classification of various types of cancers. In this study, we present findings that squamous epithelial cells in laryngeal carcinoma, which appear morphologically intact during conventional pathohistological evaluation, have distinct nuclear GLCM and DWT features. The average values of nuclear GLCM indicators of these cells, such as angular second moment, inverse difference moment, and textural contrast, substantially differ when compared to those in noncancerous tissue. In this work, we also propose machine learning models based on random forests and support vector machine that can be successfully trained to separate the cells using GLCM and DWT quantifiers as input data. We show that, based on a limited cell sample, these models have relatively good classification accuracy and discriminatory power, which makes them suitable candidates for future development of AI-based sensors potentially applicable in laryngeal carcinoma diagnostic protocols.

Authors

  • Svetlana Valjarevic
    University of Belgrade, Faculty of Medicine, Clinical Hospital Center "Zemun", Vukova 9, 11080, Belgrade, Serbia.
  • Milan B Jovanovic
    University of Belgrade, Faculty of Medicine, Clinical Hospital Center "Zemun", Vukova 9, RS-11080 Belgrade, Serbia.
  • Nenad Miladinovic
    University of Belgrade, Faculty of Medicine, Clinical Hospital Center "Zemun", Vukova 9, RS-11080 Belgrade, Serbia.
  • Jelena Cumic
    University of Belgrade, Faculty of Medicine, Clinical Center of Serbia, Dr. Koste Todorovića 8, RS-11129, Belgrade, Serbia.
  • Stefan Dugalic
    University of Belgrade, Faculty of Medicine, University Clinical Center of Serbia, Dr. Koste Todorovica 8, RS-11129 Belgrade, Serbia.
  • Peter R Corridon
    Department of Immunology and Physiology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, PO Box 127788, Abu Dhabi, United Arab Emirates; Biomedical Engineering, Healthcare Engineering Innovation Center, Khalifa University of Science and Technology, PO Box 127788, Abu Dhabi, United Arab Emirates; Center for Biotechnology, Khalifa University of Science and Technology, PO Box 127788, Abu Dhabi, United Arab Emirates.
  • Igor Pantic
    University of Belgrade, Faculty of Medicine, Institute of Medical Physiology, Laboratory for Cellular Physiology, Visegradska 26/II, RS-11129, Belgrade, Serbia; University of Haifa, 199 Abba Hushi Blvd. Mount Carmel, Haifa, IL-3498838, Israel. Electronic address: igorpantic@gmail.com.